For decades, taking a daily low-dose aspirin was a widely accepted practice for preventing heart attacks and strokes. But a ...

Cardiovascular disease is the number one cause of death in the United States, at a cost of about 700,000 lives per year. For ...

Nearly one in three Americans over the age of 60 — roughly 19 million people — take aspirin daily, according to a 2021 study.

Daily low-dose aspirin can help prevent cancers from returning in about a third of colon cancer patients, a new study says.

Daily low-dose aspirin reduced the risk for colorectal cancer recurrence by roughly half in patients with mutations in the ...

Further trials comparing aspirin with newer anticoagulants (dabigatran ... Based on the RE-LY study, a 150-mg dose of dabigatran as compared with warfarin was shown to reduce the rate of stroke ...

The prevalence of daily low-dose aspirin use fell significantly after the American College of Cardiology and the American ...

Aspirin has been shown to effectively reduce recurrence rates and improve disease-free survival,” said Anna Martling, MD, PhD.

Aspirin use in patients with PI3K-mutated colorectal cancer helped to reduce disease recurrence, highlighting the importance ...

Low-dose aspirin significantly reduced risk for colorectal cancer recurrence among patients with mutations in the PI3K ...

Three-year results from the ALASCCA trial (NCT02647099), presented at the 2025 ASCO Gastrointestinal Cancer Symposium, showed ...

Many historically underrepresented groups, individuals on Medicaid and some without insurance at low atherosclerotic risk continue to take low-dose aspirin despite bleeding risk, in contrast to recent ...